increased glutathione in acute myeloid leukemia Metabolic reprogramming and immune regulation Targeting Aberrant Glutathione Metabolism to
Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells ScienceDirect Glutamine and leukemia research: progress and clinical prospects Discover Oncology Springer Nature Link Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response Leukemia ABCC1 and glutathione metabolism limit the efficacy of BCL 2 inhibitors in acute myeloid leukemia Nature Communications
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



